financetom
Business
financetom
/
Business
/
Five charts on the Japanese yen's decades-long drop
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Five charts on the Japanese yen's decades-long drop
Apr 29, 2024 5:48 AM

LONDON (Reuters) - Japan's yen saw a sudden jump on Monday, suggesting the country's authorities may have finally followed through on the FX market intervention warnings they have be making for months.

Monday's moves follow a near-11% drop in the yen's value against the dollar this year and a 35% slump over the last three decades that has pushed it to a 34-year low.

Here are five charts to show what has been happening.

1/INTERVENTION EFFORTS

Monday's suspected intervention came after the yen dived past 160 to the dollar, well below where most FX traders had thought it would get to before the Bank of Japan reacted.

The last time authorities intervened was in September and October of 2022. They were estimated to have spent as much as 9.2 trillion yen ($60.78 billion) defending the currency at that time.

The other big effort came during the Asian financial crisis in 1998, when the yen lost almost 25% in just 14 months and reached nearly 148 per dollar in August that year. The United States joined in with the intervention push and the yen rallied over 35% in the following four months.

There has been intervention in the opposite direction too. In March 2011, Group of Seven (G7) nations jointly stepped in to stem yen strength when the currency spiked to a record high in the aftermath of a major earthquake that also crippled the large Fukushima nuclear plant.

2/TOKYO DRIFT

This isn't a sudden thing. The yen has been universally weak over the last four years. Not only is it down 31% against the greenback over this period, it is down 29% against China's currency, 29.5% against the euro and nearly 36% against the safe-haven Swiss franc.

3/STOCK UP

The weak yen has been no bad thing for Japan's stock market which is filled with companies that sell their products around the world. The weak yen keeps them competitive and has helped lift the market over 162% over the last decade, which is not far off the 174% rise the U.S. S&P 500 has seen over the same timeframe.

4/YIELD VS YEN

One of the main drivers of the yen's weakness is that Japanese interest rates are far lower than elsewhere in the world. Benchmark 10-year U.S. government bonds, for example, currently yield 3.7 percentage points more than Japan's.

This differential means it is not appealing for big international investors like pension funds to buy those Japanese government bonds, or JGBs as they are known, which it turn caps the demand for the yen.

Japan's government debt-to-GDP ratio is also among the highest in the world, having more than trebled to close to 260% from 85% back in 1994.

5/WHERE WE ARE AT

The yen's drop since the start of January is its third worst start to a year in the last three decades and the fifth time in the last six years that it has been down at this stage of the year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioCryst to buy Astria Therapeutics in $700 million deal
BioCryst to buy Astria Therapeutics in $700 million deal
Oct 14, 2025
Oct 14 (Reuters) - BioCryst Pharmaceuticals ( BCRX ) said on Tuesday it would buy Astria Therapeutics ( ATXS ) in a cash-and-stock deal valued at about $700 million, as it looks to expand its portfolio of treatments for rare diseases. ...
GSK Says China Approves Vaccine for Prevention of Shingles
GSK Says China Approves Vaccine for Prevention of Shingles
Oct 14, 2025
07:17 AM EDT, 10/14/2025 (MT Newswires) -- GSK (GSK) said Tuesday that the China National Medical Products Administration has approved Shingrix, its Recombinant Zoster Vaccine for the prevention of shingles, or herpes zoster, in adults aged 18 years and over. The company said its application was informed by six clinical trials in patients aged 18 years and up who had...
BRIEF-BioCryst To Acquire Astria Therapeutics, Strengthening Presence In Hae, Transforming Growth Profile
BRIEF-BioCryst To Acquire Astria Therapeutics, Strengthening Presence In Hae, Transforming Growth Profile
Oct 14, 2025
Oct 14 (Reuters) - Astria Therapeutics Inc ( ATXS ): * BIOCRYST TO ACQUIRE ASTRIA THERAPEUTICS, STRENGTHENING PRESENCE IN HAE, TRANSFORMING GROWTH PROFILE * BIOCRYST PHARMACEUTICALS ( BCRX )- DEAL VALUED AT $13.00 PER ASTRIA SHARE, $700 MILLION ENTERPRISE VALUE * ASTRIA THERAPEUTICS INC ( ATXS ) - BIOCRYST TO PAY $8.55 CASH AND 0.59 SHARES PER ASTRIA SHARE *...
Australian, New Zealand Dollars Hit by New Phase of U.S.-China Trade Escalation, Says Mitsubishi UFG
Australian, New Zealand Dollars Hit by New Phase of U.S.-China Trade Escalation, Says Mitsubishi UFG
Oct 14, 2025
07:20 AM EDT, 10/14/2025 (MT Newswires) -- The worst-performing currencies during the Asian trading session on Tuesday were the G10 commodity currencies of the Australian (AUD) and New Zealand (NZD) dollars, said MUFG. It resulted in the AUD/USD rate falling to a fresh low as it moves closer to support from the 200-day moving average that comes in at around...
Copyright 2023-2026 - www.financetom.com All Rights Reserved